Blog
RSS FeedPosted by Michael Wonder on 08 Oct 2024
The FDA approved a self-administered nasal spray for the flu. Here’s how it compares to the traditional flu shot.
6 October 2024 - The US FDA recently approved FluMist as a self or caregiver-administered nasal spray flu vaccine to prevent ...
Posted by Michael Wonder on 02 Mar 2023
PHARMAC confirms widened access for the funded flu vaccine
2 March 2023 - PHARMAC is widening access to the annual funded flu vaccine to tamariki aged 6 months to 12 ...
Posted by Michael Wonder on 10 Dec 2022
Pfizer and BioNTech receive US FDA fast track designation for single dose mRNA based vaccine candidate against COVID-19 and influenza
9 December 2022 - Pfizer and BioNTech today announced the companies have received fast track designation from the US FDA ...
Posted by Michael Wonder on 07 Sep 2022
First combination COVID-19 and influenza self-tests approved for Australia
7 September 2022 - The TGA has approved the first two nasal combination self-tests (for use at home) that detect ...
Posted by Michael Wonder on 26 Jun 2022
PHARMAC widens flu vaccine access to increase uptake
27 June 2022 - PHARMAC today announced that it is permanently widening access to the annual funded flu vaccine to people ...
Posted by Michael Wonder on 17 May 2022
FDA authorises first COVID-19 test available without a prescription that also detects influenza and RSV
16 May 2022 - The EUA authorises at home sample collection with testing performed in a laboratory. ...
Posted by Michael Wonder on 07 Apr 2022
Concerns two different flu vaccines create two tier system for 65 and overs
8 April 2022 - PHARMAC is being accused of kicking an own goal on flu jabs, after those aged 65 ...
Posted by Michael Wonder on 29 Mar 2022
Seqirus receives Health Canada approval for expanded age indication of its cell-based quadrivalent influenza vaccine for people as young as six months
28 March 2022 - Seqirus announced today that it has received Health Canada approval of Flucelvax Quad (influenza vaccine), its cell-based ...
Posted by Michael Wonder on 28 Mar 2022
2022 seasonal influenza vaccines
25 March 2022 - The Australian Influenza Vaccine Committee has reviewed data related to epidemiology, antigenic and genetic characteristics of recent ...
Posted by Michael Wonder on 20 Mar 2022
ProCare supports PHARMAC’s proposal to widen access to the flu vaccine
18 March 2022 - Leading health care provider ProCare has today made a submission in support of PHARMAC’s proposal to ...
Posted by Michael Wonder on 07 Mar 2022
PHARMAC proposes widened access to the flu vaccine for Māori and Pacific peoples for 2022 season
8 March 2022 - PHARMAC is consulting on a proposal to widen access to the funded influenza vaccine to include Māori ...
Posted by Michael Wonder on 28 Feb 2022
Flu vaccine price increase
1 March 2022 - PHARMAC has confirmed that the purchase price of the annual influenza vaccine will increase by $2 ...
Posted by Michael Wonder on 29 Jun 2021
Update of EU recommendations for 2021–2022 seasonal flu vaccine composition
28 June 2021 - EMA has issued an update of the EU recommendations for the influenza virus strains that vaccine ...
Posted by Michael Wonder on 27 Apr 2021
Flu vaccine war: chemists accused of delivering weaker jab
27 April 2021 - A war has broken out between chemists and doctors, who say elderly Australians are being given an ...
Posted by Michael Wonder on 24 Mar 2021
Seqirus ready to reinforce Canada's influenza pandemic preparedness plans
23 March 2021 - Health Canada's approval of Foclivia (an adjuvanted, egg-based A strain H5N1 pandemic influenza vaccine) meets key requirement ...